Clinical usefulness of measuring urinary polyol excretion by gas-chromatography/mass-spectrometry in type 2 diabetes to assess polyol pathway activity.
about
The pathogenesis of diabetic retinopathy: old concepts and new questions.Inhibition of aldose reductase activates hepatic peroxisome proliferator-activated receptor-α and ameliorates hepatosteatosis in diabetic db/db mice.Novel insights in the treatment of diabetic nephropathy.Gremlin gene expression in bovine retinal pericytes exposed to elevated glucoseRegulation of plasma fructose and mortality in mice by the aldose reductase inhibitor lidorestat.Aldose reductase regulates hepatic peroxisome proliferator-activated receptor alpha phosphorylation and activity to impact lipid homeostasis.Electrokinetic probes for single-step screening of polyol stereoisomers: the virtues of ternary boronate ester complex formation.A fiber-optic sorbitol biosensor based on NADH fluorescence detection toward rapid diagnosis of diabetic complications.The complex human urinary sugar profile: determinants revealed in the cross-sectional KarMeN study
P2860
Q34658478-B5977C2D-EB14-47F8-A1A2-D986BF2173FBQ35550716-C2B701D4-E31D-4F35-AB08-6DE6E68A3528Q37070946-B7A8DDA6-01EB-4FE5-81F0-7F77D69AEDEEQ41812757-D45D8C0E-E2E2-4122-9ABE-F2C36EBE023BQ42139014-7C22EDF6-6FC9-469E-968D-13DD98CC6965Q46003997-AAB65C85-985E-48B2-98A7-72B01BC06912Q46655643-81A51F60-08A7-4E9A-8FAA-FE3BAFE169C1Q46689799-0EBCAC58-33EB-4F11-9B52-653C1A2D5572Q58751491-33D3BBC0-7084-43ED-8AB1-A6E0EFA3506E
P2860
Clinical usefulness of measuring urinary polyol excretion by gas-chromatography/mass-spectrometry in type 2 diabetes to assess polyol pathway activity.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical usefulness of measuri ...... ssess polyol pathway activity.
@ast
Clinical usefulness of measuri ...... ssess polyol pathway activity.
@en
type
label
Clinical usefulness of measuri ...... ssess polyol pathway activity.
@ast
Clinical usefulness of measuri ...... ssess polyol pathway activity.
@en
prefLabel
Clinical usefulness of measuri ...... ssess polyol pathway activity.
@ast
Clinical usefulness of measuri ...... ssess polyol pathway activity.
@en
P2093
P1476
Clinical usefulness of measuri ...... ssess polyol pathway activity.
@en
P2093
P304
P356
10.1016/S0168-8227(00)00221-7
P577
2001-02-01T00:00:00Z